3rd International Workshop on HIV Pediatrics held on July 15-16, 2011 at Rome, Italy

  1. Saksawad R, Puthanakit T, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K. High prevalence of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. [Poster # P_7]
    http://pag.ias2011.org/EPosterHandler.axd?aid=2461
    http://www.virology-education.com/index.cfm/t/Workshop_Material/vid/76B796DC-EA57-B86F-25-F46BE5945C0911
    Reviews in Antiviral Therapy & Infectious Diseases 2011_8: Pages 45-46
  2. Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T. The Immunogenicity and Safety of Pneumococcal Conjugate Vaccine in Human Immunodeficiency Virus-Infected Thai Children. [Poster # P_94 ]
    http://www.virology-education.com/index.cfm/t/Workshop_Material/vid/76B796DC-EA57-B86F-5F46BE5945C0911
    Reviews in Antiviral Therapy & Infectious Diseases 2011_8: Pages 114-115
    http://f1000.com/posters/view/document/1089313
  3. Bunupuradah T, Ubolyam S, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Pinyakorn S, Ananworanich J, Sirinuch A, van der Lugt J, Luplertlop N, Ruxrungtham K , Puthanakit T on behalf of the PREDICT study group. Impact of Selenium and Zinc level on antiretroviral treatment outcomes in Thai HIV-infected children. [Poster # P_29]*
    http://pag.ias2011.org/EPosterHandler.axd?aid=3372
    http://www.virology-education.com/index.cfm/t/Workshop_Material/vid/76B796DC-EA57-B86F- 25F46BE5945C0911
    Reviews in Antiviral Therapy & Infectious Diseases 2011_8: Pages 62-63
    http://f1000.com/posters/view/document/1089314
  4. Bunupuradah T, Puthanakit T, Fahey P, Kariminia A, Yusoff NKN, Khanh TH, Sohn A, Chokephaibulkit K, Lumbiganon P, Hansudewechakul R, Razali K, Kurniati N, Huy BV, Sudjaritruk T, Kumarasamy N, Fong SM, Saphonn V, Ananworanich J on behalf of TApHOD. Second-line highly active antiretroviral therapy in Asian HIV-infected children. [Poster # P_37]
    http://www.med.cmu.ac.th/dept/pediatrics/04-divisions_home_thai/09-id-home/ID-2-hiv/05-poster/2011/Second%20Line%20Poster_Torsak_Tavitiya.pdf
    http://regist2.virology-education.com/2011/3HIVped/docs/13_Bunupuradah.pdf
    http://www.virology-education.com/index.cfm/t/Workshop_Material/vid/76B796DC-EA57-B86F-25-F46BE5945C0911
    Reviews in Antiviral Therapy & Infectious Diseases 2011_8: Page 31
  5. Bunupuradah T, Puthanakit T, Kosalaraksa P, Kerr S, Boonrak P, Prasitsuebsai W, Lumbiganon P, Mengthaisong T, Phasomsap C, Pancharoen C, Ruxrungtham K, Ananworanich J and the HIV-NAT Pediatric Study Team. Immunologic and virologic failure after first-line highly active antiretroviral therapy in HIV-infected children. [Poster # P_37]*
    http://www.virology-education.com/index.cfm/t/Workshop_Material/vid/76B796DC-EA57-B86F-25-F46BE5945C0911
    Reviews in Antiviral Therapy & Infectious Diseases 2011_8: Pages 68-69
    http://f1000.com/posters/view/document/1089315

* Also presented at IAS conference